Category Genetics

12 Jul

Male & Female Stem Cells Derived from the Same Person with the Same Genetic Code

Stem cells have been making headlines for the past three decades for good reason – they are master cells, capable of generating nearly any specialised cell in the human body.   Our ability to manipulate and replicate these cells holds tremendous hope for regenerative medicine,  to test the safety and effectiveness of treatments, and understand […]

READ MORE

8 Mar

Hadassah’s New Gene Targeting Tool Can Improve Cancer Treatment Outcomes for Patients

Hadassah Cancer Research Institute at the Hadassah University Hospital in Jerusalem, announced last month that researchers have designed a genomic analysis tool for cancer patients that enables advanced selection of drugs targeting schemes for cancer genes, opening the door to improved personalised medicine in cancer treatment.   The science behind this breakthrough tool is a […]

READ MORE

16 Feb

Predictive-AI Algorithm Successfully Identifies Common Cancerous Gene Mutations at Hadassah Cancer Research Institute

Breakthrough research at Hadassah identifies all possible cancer-causing mutations of a key gene (TP53) found in 50% of tumours. The Hadassah Cancer Research Institute at the Hadassah University Medical Centre in Jerusalem, announced today that using artificial intelligence (AI), researchers have developed, an algorithm to identify, with an unprecedented 96.5% level of accuracy, all possible deleterious […]

READ MORE

12 Jan

Hadassah’s Revolution in Scientific Research: What are Organoids?

Classically, researchers in basic medical science have had two tools: in vitro cultures and animal models. The limitations pose many challenges: Cells taken out of the human body and grown in a petri dish won’t behave exactly as they do within a real organ of the body. Animal models are not as highly complex as the human body. […]

READ MORE

17 Dec

Hadassah and Neurogenesis announce results from Phase 2 MS Study

A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat neurodegenerative diseases. The 14-month randomized, double blind, placebo-controlled study, comprised of 48 patients, was led by Prof. […]

READ MORE

10 Jul

Hadassah’s Wohl Institute Provides Tools for Researchers to Advance

Just six months have passed since the Wohl Institute for Translational Medicine opened at Hadassah Hospital Ein Kerem, but it has already become the focus of 30 research projects from Hadassah. “In such a short time, with nearly half of it dominated by COVID-19, we’ve established ourselves as a national centre,” says Institute Director Prof. […]

READ MORE

21 Jan

Welcome to the decade when medicine meets sci-fi fantasy

Edited from an article in The Times, 17 January 2020. Thanks to AI and genome editing, age-defying treatment breakthroughs that were just out of our reach should become reality, says Tom Whipple. In the next ten years medicine will get cleverer, more targeted and personalised. But what is personalised medicine? Experimental genetic therapies find their way […]

READ MORE

9 Jan

HADASSAH IS FIRST IN MIDDLE EAST TO USE NEW TUMOUR DIAGNOSTIC TEST

Hadassah Medical Centre in Jerusalem, a leader in the field of molecular diagnosis of tumours, has announced that its Molecular Pathology and Diagnostic Tumours department is now the first location in the Middle East and third outside of the United States to conduct a unique tumour diagnostic test within its own laboratories that help inform […]

READ MORE

19 Dec

International Lifetime Achievement Award Goes To Hadassah Psychiatrist

The International Society for Affective Disorders (ISAD) has honoured the Hadassah Medical Centre’s pioneering psychiatrist Prof. Bernard Lerer with its first-ever Lifetime Achievement Award. Prof. Lerer, 71, was born in South Africa and moved to Israel as a young physician. He entered the field of psychiatry just after the revolutionary anti-psychotic and anti-depressant drugs like […]

READ MORE

18 Nov

Hadassah /Oxford University Study of Bone Fragility Among Diabetics Receives Research Grant

Prof. Rivka Dresner Pollak, head of the Hadassah Medical Organisation’s Department of Endocrinology and Metabolism, together with University of Oxford colleague Prof. Lynne Cox, has received funding for a three-year joint project to study age-related bone fragility in patients with type 1 diabetes who are currently at high risk of bone fracture and premature death, […]

READ MORE
Subscribe

Join our digital newsletter to stay in touch with the latest news from Hadassah UK